Akers Biosciences, Inc.
|Number of Estimates|
Akers Biosciences, Inc. engages in the development, manufacture, and supply of screening and testing products. Its products include clinical diagnostics and safety tests. The company was founded by Raymond Francis Akers, Jr. and Raymond F. Akers, Sr. on March 8, 1989 and is headquartered in West Deptford, NJ.
Market Cap: 21.8 Million
Primary Exchange: NASDAQ
Shares Outstanding: 6.12 Million
Float: 5.73 Million
Sector: Health Technology
Industry: Medical Specialties
Longest drawdown: 1995 trading days
From: 2013-10-21 To: 2019-11-22
|Ex-Date||Payment Date||Record Date||Declared Date||Amount||Flag||Dividend Type||Qualified||Indicated|
|Ex-Date||Declared Date||Record Date||Payment Date||Ratio||To Factor||For Factor|